newsfilter
← Latest News
GlobeNewswire·

Otonomy to Participate in the H.C. Wainwright BioConnect Conference

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the H.C. Wainwright BioConnect Virtual